To obtain insight into the relative contribution of HNSCC-derived galanin to the immunomodulatory effects, two approaches were used to reduce galanin: siRNA-mediated silencing in HNSCC cells and antibody-mediated depletion of CM. Here, GAL is linked to head and neck squamous cell carcinoma.